4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-18-018323
Director acquired 4,152 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Albers Jeffrey W. Director | 2018-06-25 | Conversion | +4,152 | 4,152 | D | ||
| Derivatives | |||||||
| Albers Jeffrey W. Director | 2018-06-25 | Conversion · Series C Preferred Stock | −10,729 | 0 | D | ||
Loading xslF345X03/doc4.xml…